Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | -0.24% | 343.28 | 1.2% | $589.37m | |
| GILD | Gilead Sciences, Inc. | 1.33% | 73.32 | 0.9% | $534.10m | |
| CELG | Celgene Corporation | 0.35% | 91.20 | 1.2% | $502.04m | |
| AMGN | Amgen Inc. | -0.13% | 197.31 | 1.2% | $470.98m | |
| ILMN | Illumina, Inc. | 1.67% | 331.44 | 3.5% | $390.25m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.00% | 378.56 | 2.6% | $309.76m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.65% | 176.86 | 1.9% | $202.70m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.71% | 116.99 | 2.0% | $186.49m | |
| A | Agilent Technologies, Inc. | 0.75% | 64.95 | 1.5% | $163.20m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.18% | 129.14 | 16.6% | $139.77m | |
| NKTR | Nektar Therapeutics | 2.24% | 61.96 | 5.6% | $128.47m | |
| EXAS | Exact Sciences Corporation | 1.71% | 50.05 | 25.3% | $122.85m | |
| BLUE | Bluebird Bio, Inc. | 0.06% | 158.80 | 14.6% | $120.19m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.72% | 99.74 | 4.4% | $119.07m | |
| INCY | Incyte Corporation | 0.83% | 69.62 | 2.5% | $116.18m |
Company Profile
Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. It operates through the United States and Europe geogrpahical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.